October 02, 2025

FDA Removes Vandetanib REMS Program

On September 25, the U.S. Food and Drug Administration (FDA) removed the Risk Evaluation and Mitigation Strategies (REMS) program for vandetanib, according to an announcement from the agency. 

The ASCO Post

October 02, 2025

Cardiac Rehab Success: Patient Recovery and Support After Cardiac Arrests

“Heart disease is the number one killer of all women everywhere,” Ms. Campos says. “Unfortunately, our stories are not as unique as we wish they were.”

Baptist Health South Florida

October 01, 2025

Shutdown Showdown: How Long Can Health Services Last?

Federal shutdown suspends some health services, limits National Institutes of Health research, and raises questions about Affordable Care Act subsidies, Medicaid, and public health programs.

KFF Health News

October 01, 2025

How Safe Are FDA-Cleared AI Tools?

“These findings indicate that standardized efficacy, safety, and risk assessment reporting remains inadequate for FDA-cleared AI/ML devices, underscoring the need for dedicated regulatory pathways and robust postmarket surveillance to ensure patient safety."

Conexiant

October 01, 2025

Beyond CPAP: Exploring Alternative Therapies for Sleep Apnea Management

An 83-year-old Air Force veteran and longtime Miami resident was diagnosed with obstructive sleep apnea (OSA), a condition that caused him to stop breathing dozens of times every hour as he slept.

Baptist Health South Florida

September 29, 2025

Clinicians: Ultraprocessed Food Limits Coming to Cafeterias?

States consider bipartisan bans on ultraprocessed foods in schools over obesity and child health.

KFF Health News

September 29, 2025

ACC Calls for Universal Inflammation Screening

New scientific statement positions hsCRP testing alongside cholesterol as evidence mounts for targeting residual inflammatory risk. 

Conexiant

September 29, 2025

Meta-Analysis Finds Higher Cardiovascular Risk in IPF

Cardiovascular disease occurs more often in patients with idiopathic pulmonary fibrosis.

Conexiant

September 29, 2025

Levodopa Investigated for Stroke Rehabilitation: ESTREL Trial

Swiss trial across 13 stroke units and 11 rehab centers challenges levodopa use in stroke recovery.

Conexiant